ISRCTN75594310
Completed
N/A
Randomised controlled trial of Active Children Through Individual Vouchers Evaluation (ACTIVE)
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Teenage obesity
- Sponsor
- Swansea University
- Enrollment
- 986
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
2017 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/28693484 protocol 2018 Results article in https://www.ncbi.nlm.nih.gov/pubmed/29558987 qualitative results (added 14/06/2019) 2019 Results article in https://www.ncbi.nlm.nih.gov/pubmed/31079080 qualitative results (added 14/06/2019) 2020 Results article in https://www.ncbi.nlm.nih.gov/pubmed/31859172 results (added 23/12/2019) 2019 Interim results article in https://pubmed.ncbi.nlm.nih.gov/31749974/ (added 26/04/2023)
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Participants must be aged 13 \- 14 years old
- •2\. Must be from one of the 7 schools selected (selected via FSM eligibility)
- •3\. Must provide informed consent
Exclusion Criteria
- •Unable to provide informed consent
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
Developing and evaluating multimedia information resources to improve engagement of children, adolescents and their parents with trialsong-term health conditionsNot ApplicableISRCTN73136092niversity of York1,906
Completed
N/A
Randomised controlled trial (RCT) of a children's hospital at home servicePyrexia, diarrhoea, vomiting, respiratory difficultiesNot ApplicableISRCTN11421664HS R&D Regional Programme Register - Department of Health (UK)399
Completed
N/A
Web-based Physical Activity Intervention for ChildrenPhysical Activity in ChildrenNCT05254483University of Wisconsin, Madison82
Completed
N/A
A randomized controlled trial of an empowerment intervention for female adolescents with diabetes.DiabetesNutritional, Metabolic, EndocrineType 1 diabetesISRCTN57528404Karolinska Institute / Södersjukhuset100
Active, Not Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of Mitapivat in Pediatric Participants With Pyruvate Kinase Deficiency (PKD) Who Are Regularly Transfused, Followed by a 5-Year Extension PeriodPediatric Pyruvate Kinase DeficiencyPediatric Hemolytic AnemiaNCT05144256Agios Pharmaceuticals, Inc.49